The brain-gut axis: A target for treating stress-related disorders

Inflammation in Psychiatry

Volumn 28, Issue , 2013, Pages 90-99

  Scott, Lucinda V ^a   Clarke, Gerard ^a   Dinan, Timothy G ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b University College Cork and INFANT Centre   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84895864682     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000343971     Document Type: Chapter

References (65)

1. O'Mahony SM, Hyland NP, Dinan TG, Cryan JF: Maternal separation as a model of brain-gut axis dysfunction. Psychopharmacology (Berl) 2011;214: 71-88.
2. Rhee SH, Pothoulakis C, Mayer EA: Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009;6: 306-314.
3. Cryan JF, O'Mahony SM: The microbiome-gut-brain axis: from bowel to behavior. Neurogastroenterol Motility 2011;23:187-192.
4. Grenham S, Clarke G, Cryan JF, Dinan TG: Brain-gut-microbe communication in health and disease. Front Physiol 2011;2:94.
5. Gill SR, Pop M, Deboy RT, Eckburg PB, Turnbaugh PJ, Samuel BS, Gordon JI, Relman DA, Fraser-Liggett CM, Nelson KE: Metagenomic analysis of the human distal gut microbiome. Science 2006;312: 1355-1359.
6. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C, et al: A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464:59-65.
7. Ley RE, Peterson DA, Gordon J: Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006;124:837-848.
8. Xu J, Mahowald MA, Ley RE, Lozupone CA, Hamady M, Martens EC, Henrissat B, Coutinho PM, et al: Evolution of symbiotic bacteria in the distal human intestine. PLoS Biol 2007;5:e156.
9. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA: Diversity of the human intestinal microbial flora. Science 2005;308:1635-1638.
10. Shanahan F: Gut microbes: from bugs to drugs. Am J Gastroenterol 2010;105: 275-279.
11. Sekirov I, Russell SL, Antunes LCM, Finlay BB: Gut microbiota in health and disease. Physiol Rev 2010;90:859-904.
12. Archie E, Theis K: Animal behaviour meets microbial ecology. Anim Behav 2012;in press.
13. O'Hara AM, Shanahan F: The gut flora as a forgotten organ. EMBO Rep 2006;7: 688-693.
14. Forsythe P, Sudo N, Dinan T, Taylor VH, Bienenstock J: Mood and gut feelings. Brain Behav Immun 2010;24:9-16.
15. Mackie RI, Sghir A, Gaskins HR: Developmental microbial ecology of the neonatal gastrointestinal tract. Am J Clin Nutrit 1999;69:1035S-1045S.
16. Palmer C, Bik EM, Digiulio DB, Relman DA, Brown PO: Development of the human infant intestinal microbiota. PLoS Biol 2007;5:e177.
17. Kurokawa K, Itoh T, Kuwahara T, Oshima K, Toh H, Toyoda A, Takami H, Morita H, Sharma VK, Srivastava TP: Comparative metagenomics revealed commonly enriched gene sets in human gut microbiomes. DNA Res 2007;14:169.
18. Adlerberth I, Wold AE: Establishment of the gut microbiota in Western infants. Acta Paediatr 2009;98:229-238.
19. Claesson MJ, Cusack S, O'Sullivan O, Greene-Diniz R, de Weerd H, Flannery E, et al: Composition, variability, and temporal stability of the intestinal microbiota of the elderly. Proc Natl Acad Sci USA 2011;108(suppl 1): 4586-4591.
20. Woodmansey EJ: Intestinal bacteria and ageing. J Appl Microbiol 2007;102: 1178-1186.
21. Sudo N, Chida Y, Aiba Y, Sonoda J, Oyama N, Yu XN, et al: Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. J Physiol 2004;558:263-275.
22. Dinan TG, Cryan J: Regulation of the stress response by the gut microbiota: implications for psychoneuroendocrinology. Psychoneuroendocrinology 2012;in press.
23. Neufeld K, Kang N, Bienenstock J, Foster J: Reduced anxiety like behavior and central neurochemical change in germ free mice. Neurogastroenterol Motil 2011;23:255-264.
24. O'Mahony SM, Marchesi JR, Scully P, Codling C, Ceolho AM, Quigley EMM, Cryan JF, Dinan TG: Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses. Biol Psychiatr 2009;65:263-267.
25. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF: Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011;108: 16050-16055.
26. Rousseaux C, Thuru X, Gelot A, Barnich N, Neut C, Dubuquoy, et al: Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nat Med 2007;13:35-37.
27. Desbonnet L, Garrett L, Clarke G, Bienenstock J, Dinan TG: The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat. J Psychiatr Res 2008;43:164-174.
28. Ruddick JP, Evans AK, Nutt DJ, Lightman SL, Rook GA, Lowry CA: Tryptophan metabolism in the central nervous system: medical implications. Expert Rev Mol Med 2006;8:1-27.
29. Bercik P, Park AJ, Sinclair D, Khoshdel A, Lu J, Huang X, et al: The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 2011;23:1132-1139.
30. Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, Mac-Queen G, Sherman PM: Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011;60:307-317.
31. McKernan DP, Fitzgerald P, Dinan TG, Cryan JF: The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat. Neurogastroenterol Motil 2010;22:1029-1035.
32. Messaoudi M, Lalonde R, Violle N, Javelot H, Desor D, Nejdi A, et al: Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. Br J Nutr 2011;105:755-764.
33. Dinan TG, Quigley E, O'Mahony S, O'Mahony L, Scully P, Shanahan F, Keeling PWN: Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? Gastroenterology 2006;130: 304-311.
34. Quigley EM: Do patients with functional gastrointestinal disorders have an altered gut flora? Therap Adv Gastroenterol 2009;2:23-30.
35. Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM: Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology 2006;131:445-450.
36. Spiller RC, Jenkins D, Thornley JP, Hebden JM, Wright T, Skinner M, Neal KR: Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut 2000;47:804-811.
37. Dunlop SP, Jenkins D, Neal KR, Spiller RC: Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS. Gastroenterol 2003;125:1651-1659.
38. Gwee K, Collins S, Read N, Rajnakova A, Deng Y, Graham J, Mckendrick M, Moochhala S: Increased rectal mucosal expression of interleukin 1 in recently acquired post-infectious irritable bowel syndrome. Gut 2003;52:523.
39. Chadwick VS, Chen W, Shu D, Paulus B, Bethwaite P, Tie A, Wilson I: Activation of the mucosal immune system in irritable bowel syndrome. Gastroenterology 2002;122:1778-1783.
40. Collins SM, Denou E, Verdu EF, Bercik P: The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis 2009;41:850-853.
41. Barbara G, Stanghellini V, De Giorgio R, Cremon C, Cottrell GS, Santini D, Pasquinelli G, Morselli-Labate AM, Grady EF, Bunnett NW, Collins SM, Corinaldesi R: Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome. Gastroenterology 2004;126:693-702.
42. Cenac N, Andrews CN, Holzhausen M, Chapman K, Cottrell G, Andrade-Gordon P, Steinhoff M, Barbara G, Beck P, Bunnett NW, Sharkey KA, Ferraz JGP, Shaffer E, Vergnolle N: Role for protease activity in visceral pain in irritable bowel syndrome. J Clin Invest 2007;117:636-647.
43. O'Mahony L, McCarthy J, Kelly P, Shanahan F, Quigley EMM: Lactobacillus and bifidobacterium in irritable bowel syndrome: symptom responses and relationship to cytokine profiles. Gastroenterology 2005;28:541-551.
44. Dinan TG, Cryan J, Shanahan F, Keeling PW, Quigley EM: IBS: An epigenetic perspective. Nat Rev Gastroenterol Hepatol 2010;7:465-471.
45. Scully P, Mckernan DP, Keohane J, Groeger D, Shanahan F, Dinan TG, Quigley EM: Plasma cytokine profiles in females with irritable bowel syndrome and extra-intestinal co-morbidity. Am J Gastroenterol 2010;105:2235-2243.
46. McKernan DP, Gaszner G, Quigley EM, Cryan JF, Dinan TG: Altered peripheral Toll-like receptor responses in the irritable bowel syndrome. Alimenty Phar Therapeut 2011;33:1045-1052.
47. Dinan TG, Clarke G, Quigley EM, Scott LV, Shanahan F, Cryan J, Cooney J, Keeling PW: Enhanced cholinergic-mediated increase in the pro-inflammatory cytokine IL-6 in irritable bowel syndrome: role of muscarinic receptors. Am J Gastroenterol 2008;103:2570-2576.
48. Haslam DW, James WPT: Obesity. Lancet 2005;366:1197-1209.
49. Bloom SR, Kuhajda FP, Laher I, Pi-Sunyer X, Ronnett GV, Tan TMM, Weigle DS: The obesity epidemic pharmacological challenges. Mol Intervent 2008;8: 82-98.
50. Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, Semenkovich CF, Gordon JI: The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004;101:15718-15723.
51. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI: Obesity alters gut microbial ecology. Proc Natl Acadf Sci USA 2005;102:11070-11075.
52. Ley RE, Peterson DA, Gordon JI: Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006;124:837-848.
53. Bercik P, Collins SM, Verdu EF: Microbes and the brain-gut axis. Neurogastroenterol Motil 2012;24:405-413.
54. Kiliaan AJ, Saunders PR, Bijlsma PB, Berin MC, Taminiau JA, Groot JA, Perdue MH: Stress stimulates transepithelial macromolecular uptake in rat jejunum. Am J Physiol Gastrointest Liver Physiol 1998;275:G1037-G1044.
55. Demaude J, Salvador-Cartier C, Fioramonti J, Ferrier L, Bueno L: Phenotypic changes in colonocytes following acute stress or activation of mast cells in mice: implications for delayed epithelial barrier dysfunction. Gut 2006;55:655-661.
56. Freestone PP, Williams PH, Haigh RD, Maggs AF, Neal CP, Lyte M: Growth stimulation of intestinal commensal Escherichia coli by catecholamines: a possible contributory factor in traumainduced sepsis. Shock 2002;18:465-470.
57. Bailey MT, Lubach GR, Coe CL: Prenatal stress alters bacterial colonization of the gut in infant monkeys. J Pediatric Gastroenterol Nutrit 2004;38:414-421.
58. Clark E, Hoare C, Tanianis-Hughes J, Carlson GL, Warhurst G: Interferon gamma induces translocation of commensal Escherichia coli across gut epithelial cells via a lipid raft-mediated process. Gastroenterology 2005;12:1258-1267.
59. Meddings JB, Swain MG: Environmental stress-induced gastrointestinal permeability is mediated by endogenous glucocorticoids in the rat. Gastroenterology 2000;119:1019-1028.
60. Ait-Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L, Houdreau E, Fioramonti J, Bueno L, Theodorou V: Prevention of gut leakiness by intestinal microbiota modulation leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology 2012;37: 1885-1895.
61. Maes M, Kubera M, Leunis JC: The gutbrain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from Gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol Lett 2008;29:117-124.
62. Benton D, Williams C, Brown A: Impact of consuming a milk drink containing a probiotic on mood and cognition. Eur J Clin Nutr 2007;61:355-361.
63. Rao AV, Bested AC, Beaulne TM, Katzman MA, Iorio C, Berardi JM, Logan AC: A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog 2009;1:6.
64. Logan AC, Katzman M: Major depressive disorder: probiotics may be an adjuvant therapy. Med Hypotheses 2005; 64:533-538.
65. Dinan TG, Quigley EM: Probiotics in the treatment of depression: science or science fiction? Aust NZ J Psychiatr 2011; 45:1023-1025.